Diet Is Main Risk Factor for Colon Cancer in Younger Adults, New Study Suggests Aug. 14, 2024 — A new study has identified diet-derived molecules called metabolites as main drivers of young ...

MDNA11 continues to show best-in-class potential in the ABILITY-1 study with an objective response rate (ORR) of 30% in the monotherapy dose expansion cohort among patients with cancer progression aft ...

MDNA11 continues to show best-in-class potential in the ABILITY-1 study with an objective response rate (ORR) of 30% in the monotherapy dose ...

Vibostolimab/Keytruda regimen did not improve overall survival compared to Tecentriq in extensive-stage SCLC patients. Median ...

Combination Dose Escalation Tumor Response: Encouraging preliminary signs of anti-tumor activity were observed with MDNA11 in combination with KEYTRUDA in dose escalation cohorts 1 and 2. Among 5 ...

Colon cancer is the disease characterized by the development of malignant cells in the lining or epithelium of the first and longest portion of the large intestine. Starting from a single MLH1 ...

Keytruda in early-stage triple-negative breast cancer led to immune-related adverse effects, including severe GI issues and ...

Colorectal cancer, commonly known as bowel cancer, is a cancer from uncontrolled cell growth in the colon, rectum, or appendix. Symptoms typically include rectal bleeding and anemia which are ...

Colorectal cancer, or colon cancer, occurs when polyps, or growths, develop on the inner lining of the colon, according to Cleveland Clinic. If left untreated, the cancer can spread to other areas ...

“We are pleased to expand the INTerpath clinical trial program with Moderna, evaluating V940 (mRNA-4157), a promising new modality, in combination with KEYTRUDA to pursue meaningful advances for lung ...

According to the American Cancer Society, colorectal cancer “starts in the colon or the rectum.” “Most colorectal cancers start as a growth on the inner lining of the colon or rectum.